Fidia Pharma

Fidia Farmaceutici is an Italian company and world leader in the research, development, production, and marketing of hyaluronic acid and its derivatives, which have earned it a leading position in viscosupplementation worldwide. Fidia's mission is to improve people's quality of life through innovative therapies that respond effectively to the needs of doctors and patients in strategic areas such as joint care, skin care, eye care, specialty care, and health & wellness care. With research and development laboratories in Abano Terme (PD) – where the company is based – and an additional research unit in Noto, Sicily, Fidia invests heavily in innovation and boasts an internationally recognized scientific tradition. The Group has over 1,500 patents, of which more than 1,250 are dedicated to hyaluronic acid in various formulations and molecular weights. With a strong focus on internationalization, Fidia distributes its products in over 120 countries thanks to a consolidated network of partners and distributors and commercial branches in the main world markets, including Austria, Bulgaria (branch), Egypt, France, Germany, Moldova, Poland, the United Kingdom, the Czech Republic, Romania, Russia, Slovakia, Spain, the United States, Switzerland, Turkey, and the MENA region. In 2026, Fidia celebrates 80 years of scientific expertise, transforming decades of research and innovation into solutions that improve true people’s quality of life, with an ever-evolving direction. At Fidia, we are committed to fostering a professional, informative, and respectful community. Our Social Media Netiquette ensures that discussions remain ethical, compliant, and valuable for everyone. Read it here: https://www.fidiapharma.com/social-media-netiquette/ If you come across any content that breaches these rules, please report it to us directly: https://www.fidiapharma.com/our-group/contacts/